Clinical TrialsSearch results
Number of results: 553
Other
- A randomized, double-blind, placebo-controlled, cross-over, multi-center study concerning the efficacy and safety of amantadine hydrochloride in treatment of dyskinesias in Parkinson's disease
- Parkinson's disease
- Comprehensive clinical study group concerning diagnosis, treatment, and prevention of the neurological disorders
- 2007-08-01
Other
- A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-03-16
Other
- A randomized, parallel-group, multicenter clinical trial to evaluate the preventive effect on acute exacerbation of chronic obstructive pulmonary disease (COPD) with Carbocisteine (1500mg/day)
- COPD
- Department of Respiratory Medicine Juntendo University, School of Medicine
- 2006-12-01
Recruiting
- A research study comparing how well different doses of the medicine NNC0519-0130 lower blood sugar in people with type 2 diabetes
- Type 2 diabetes
- Takase Juri
- 2024-03-15
Recruiting
- A Research Study to See How Switching from a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults with Type 2 Diabetes
- Type 2 Diabetes
- Tsukasaki Nobuaki
- 2024-04-12
Recruiting
- A research study to see how well new weekly medicine IcoSema, which is a combination of insulin icodec and semaglutide, controls blood sugar levels in people with type 2 diabetes, compared to daily insulin glargine(NN1535-4988:COMBINE 4)
- Type 2 diabetes
- takizaki Hiroshi
- 2024-01-26
Completed
- A research study to see how well the new weekly medicine IcoSema, which is a combination of insulin icodec and semaglutide, controls blood sugar level in people with type 2 diabetes compared to weekly insulin icodec (COMBINE1)
- type 2 diabetes
- Takizaki Hiroshi
- 2022-06-18
Other
- A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
- Early Breast Cancer
- Tanja Badovinac Crnjevic
- 2021-10-02
Other
- A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)
- Impaired glucose tolerance (IGT)
- Takeda Pharmaceutical Company Limited
- 2008-04-07
Recruiting
- A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy.
- ctDNA positive high risk MIBC
- Hajer Lassidi
- 2021-04-06